RXRX
Recursion Pharmaceuticals, Inc.
Is RXRX Halal?
AI-driven drug discovery and biotechnology — a permissible pharmaceutical research business, largely equity-funded; verify ratios as it scales.
What You Should Know
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that uses an AI- and automation-driven platform to discover and develop new medicines, advancing its own drug pipeline and partnering with large pharmaceutical companies. Drug discovery and pharmaceutical research are permissible activities with no haram revenue line. Recursion is pre-profit and funds its research primarily through equity and partnership payments rather than interest-bearing debt, holding a sizable cash runway, so it passes the debt screen. The caveats are typical clinical-stage risks: ongoing losses, volatile ratios, and interest income on its cash that should be checked against the 5% threshold and purified.
⚠️ Concerns
- •Recursion is a clinical-stage, pre-profit biotech — the activity is permissible, but the financials are speculative and should be re-screened against the latest filings
- •Interest income on its large cash runway should be confirmed against the 5% threshold and the corresponding portion of returns purified
- •Monitor any future convertible or interest-bearing financing against the 33% debt-to-market-cap threshold as the company scales
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →